Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Antibodies to spiroperidol and their anti-idiotypes as probes for studying dopamine receptors.
Genes, Fungal
Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease.
Lorcainide therapy for the high-risk patient post myocardial infarction.
Determinants of infarct size after thrombolytic treatment in acute myocardial infarction.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Determinants of infarct size after thrombolytic treatment in acute myocardial infarction.
Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Collateral Circulation
Computer Systems
Double-Blind Method
Female
Fibrinolytic Agents
Humans
Male
Middle Aged
Myocardial Infarction
Pilot Projects
Poloxamer
Radionuclide Imaging
Surface-Active Agents
Technetium Tc 99m Sestamibi
authors with profiles
Gary L Schaer